Description

Febuxostat is a potent, non-purine selective inhibitor of xanthine oxidase, a key enzyme in uric acid production. This high-purity active pharmaceutical ingredient (API) is essential for the formulation of effective treatments for chronic hyperuricemia in conditions such as gout. It is primarily required by pharmaceutical manufacturers and research institutions engaged in the development and production of advanced therapeutic agents.

Application

• Primary Active Pharmaceutical Ingredient (API) in the manufacture of oral medications for the treatment of hyperuricemia and gout.
• Key intermediate in advanced pharmaceutical research and development for next-generation xanthine oxidase inhibitors.
• Reference standard in analytical laboratories for quality control and method validation of febuxostat-based drug products.
• Critical raw material for compounding pharmacies specializing in custom dosage formulations.
• Biochemical research tool for studying purine metabolism and the pathophysiology of gout.

Basic Information

Product Name	Febuxostat
CAS No.	144060-53-7
Molecular Formula	C16H16N2O3S
Molecular Weight	316.38 g/mol
Synonyms	2-[(3-Cyano-4-isobutoxyphenyl)methyl]-4-methyl-1,3-thiazole-5-carboxylic acid; TMX-67; TEI-6720; Uloric (brand name); Adenuric (brand name); Feburic (brand name); Xanthine Oxidase Inhibitor; Non-purine Xanthine Oxidase Inhibitor
EINECS	Contact for details

Quality Control

Our Febuxostat is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets high-purity standards suitable for pharmaceutical applications. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0%
Related Substances (HPLC)	Individual impurity: NMT 0.5% Total impurities: NMT 1.5%
Loss on Drying	NMT 0.5%
Residue on Ignition	NMT 0.1%
Heavy Metals	NMT 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.